AI assistant
Sending…
Cellectar Biosciences, Inc. — Director's Dealing 2019
Jun 14, 2019
35021_dirs_2019-06-14_c1fa21a6-2a4d-449d-a39f-b24886c5ecf7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2019-06-13
Reporting Person: DRISCOLL FREDERICK W (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-06-13 | Stock option (right to buy) | $2.15 | A | 6500 | Acquired | 2029-06-13 | Common Stock (6500) | Direct |
Footnotes
F1: Options vest on the one year anniversary of the date of grant.
More from Cellectar Biosciences, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jul 10
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 29
Proxy Solicitation & Information Statement
2026
May 28
Proxy Solicitation & Information Statement
2026
May 28
Regulatory Filings
2026
May 19
Board/Management Information
2026
May 18
Earnings Release
2026
May 14
Interim / Quarterly Report
2026
May 14
Capital/Financing Update
2026
May 8